January 9, 2014
The D.C. Circuit on Tuesday revived a K-V Pharmaceutical Co.'s suit attempting to force the U.S. Food and Drug Administration to block pharmacies from producing cheaper compounded versions of K-V's preterm-birth prevention drug Makena.
quoted from here